Xeris Biopharma Holdings, Inc. (XERS)
Largest Insider Buys in Sector
XERS Stock Price History Chart
XERS Stock Performance
About Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Insider Activity of Xeris Biopharma Holdings, Inc.
Over the last 12 months, insiders at Xeris Biopharma Holdings, Inc. have bought $188,753 and sold $0 worth of Xeris Biopharma Holdings, Inc. stock.
On average, over the past 5 years, insiders at Xeris Biopharma Holdings, Inc. have bought $457,207 and sold $270,918 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Schmid John P. (director) — $59,698. Pieper Steven (See Remarks) — $54,600. Shannon John Patrick Jr (See Remarks) — $50,400.
The last purchase of 5,400 shares for transaction amount of $10,314 was made by Schmid John P. (director) on 2024‑05‑10.
List of Insider Buy and Sell Transactions, Xeris Biopharma Holdings, Inc.
| 2024-05-10 | Schmid John P. | director | 5,400 0.004% | $1.91 | $10,314 | +19.89% | ||
| 2024-03-14 | Schmid John P. | director | 4,500 0.0032% | $2.16 | $9,720 | -4.69% | ||
| 2023-11-27 | SHERMAN JEFFREY W | director | 5,400 0.004% | $1.87 | $10,098 | +16.30% | ||
| 2023-11-20 | Pieper Steven | See Remarks | 28,000 0.0218% | $1.95 | $54,600 | +17.17% | ||
| 2023-11-20 | HALKUFF DAWN | director | 5,410 0.004% | $1.84 | $9,954 | +17.17% | ||
| 2023-11-17 | Shannon John Patrick Jr | See Remarks | 30,769 0.0206% | $1.64 | $50,400 | +22.06% | ||
| 2023-11-16 | Schmid John P. | director | 6,500 0.0045% | $1.51 | $9,815 | +34.81% | ||
| 2023-11-14 | PERSKY MARLA | director | 6,370 0.0047% | $1.58 | $10,058 | +37.10% | ||
| 2023-08-09 | Edick Paul R | See Remarks | 10,000 0.0073% | $2.38 | $23,794 | -11.49% | ||
| 2022-12-13 | Edick Paul R | See Remarks | 20,000 0.0152% | $1.45 | $29,000 | +34.75% | ||
| 2022-05-12 | Edick Paul R | See Remarks | 100,000 0.0681% | $1.40 | $140,380 | +0.66% | ||
| 2022-02-22 | Sale | PRESTRELSKI STEVEN | Chief Scientific Officer | 11,228 0.0085% | $2.42 | $27,158 | -32.35% | |
| 2021-11-15 | Edick Paul R | See Remarks | 20,000 0.0151% | $2.28 | $45,664 | -17.14% | ||
| 2021-11-12 | Shannon John Patrick Jr | See Remarks | 60,000 0.0484% | $2.10 | $126,000 | -2.80% | ||
| 2021-11-11 | Edick Paul R | See Remarks | 200,000 0.1644% | $2.08 | $415,760 | 0.00% | ||
| 2021-11-11 | Shannon John Patrick Jr | See Remarks | 40,000 0.033% | $2.09 | $83,500 | 0.00% | ||
| 2021-11-10 | Pieper Steven | See Remarks | 25,000 0.0216% | $2.00 | $49,918 | +9.47% | ||
| 2021-04-12 | Sale | PRESTRELSKI STEVEN | Chief Scientific Officer | 10,000 0.0156% | $4.07 | $40,725 | -34.99% | |
| 2021-01-13 | Sale | PRESTRELSKI STEVEN | Chief Scientific Officer | 20,000 0.0341% | $6.01 | $120,116 | -43.13% | |
| 2021-01-11 | Sale | PRESTRELSKI STEVEN | Chief Scientific Officer | 20,000 0.0326% | $5.72 | $114,488 | -42.51% |
Insider Historical Profitability
| Edick Paul R | See Remarks | 2288064 1.6565% | $2.20 | 10 | 0 | +2.62% |
| Shannon John Patrick Jr | See Remarks | 1408575 1.0198% | $2.20 | 6 | 0 | +17.09% |
| Pieper Steven | See Remarks | 1176912 0.8521% | $2.20 | 2 | 0 | +9.47% |
| Schmid John P. | director | 16400 0.0047% | $2.20 | 3 | 0 | |
| PERSKY MARLA | director | 6370 0.0046% | $2.20 | 1 | 0 | |
| HALKUFF DAWN | director | 5410 0.0039% | $2.20 | 1 | 0 | |
| SHERMAN JEFFREY W | director | 5400 0.0039% | $2.20 | 1 | 0 | |
| Redmile Group, LLC | 10 percent owner | 3000642 2.1724% | $2.20 | 2 | 0 | <0.0001% |
| Palmetto Partners, Ltd. | 10 percent owner | 2110061 1.5276% | $2.20 | 1 | 0 | <0.0001% |
| Flynn James E | 10 percent owner | 856470 0.6201% | $2.20 | 1 | 10 | <0.0001% |
| PRESTRELSKI STEVEN | Chief Scientific Officer | 569780 0.4125% | $2.20 | 0 | 11 | |
| Hecht Beth | See Remarks | 57083 0.0413% | $2.20 | 3 | 0 | +37.91% |
| Deutsch Barry M. | See Remarks | 39359 0.0285% | $2.20 | 2 | 0 | +5.12% |
| JOHNSON KENNETH ERLAND | See Remarks | 6115 0.0044% | $2.20 | 2 | 0 | +5.12% |
Institutional Investor Ownership
| BlackRock | $22.01M | 6.72 | 9.96M | -0.51% | -$112,455.84 | <0.01 | |
| The Vanguard Group | $16.81M | 5.13 | 7.61M | +7.34% | +$1.15M | <0.0001 | |
| Caxton Corp | $11.3M | 3.45 | 5.11M | -9.37% | -$1.17M | 65.53 | |
| Bioimpact Capital Llc | $9.21M | 2.81 | 4.17M | +8.3% | +$705,573.43 | 1.49 | |
| State Street | $7.11M | 2.17 | 3.22M | +18.02% | +$1.08M | <0.0001 | |
| Geode Capital Management | $6.73M | 2.05 | 3.05M | +5.3% | +$338,812.32 | <0.01 | |
| Millennium Management LLC | $3.75M | 1.14 | 1.7M | +9.55% | +$326,633.57 | <0.01 | |
| Nuveen | $3.52M | 1.07 | 1.59M | +274.26% | +$2.58M | <0.01 | |
| Centerbook Partners Lp | $3.41M | 1.04 | 1.54M | +1,295.57% | +$3.17M | 0.24 | |
| Morgan Stanley | $2.85M | 0.87 | 1.29M | +5.7% | +$153,816.04 | <0.0001 | |
| Northern Trust | $2.56M | 0.78 | 1.16M | -0.5% | -$12,835.68 | <0.0001 | |
| AQR Capital | $2.52M | 0.77 | 1.14M | +317.61% | +$1.92M | <0.01 | |
| Redmile Group | $2.31M | 0.71 | 1.05M | 0% | +$0 | 0.09 | |
| Renaissance Technologies | $2.23M | 0.68 | 1.01M | -26.95% | -$822,915.27 | <0.01 | |
| Ameriprise Financial | $2.11M | 0.64 | 953,236 | +83.27% | +$957,183.44 | <0.01 | |
| D. E. Shaw & Co. | $1.56M | 0.48 | 707,011 | -32.96% | -$768,193.64 | <0.01 | |
| Bank of America | $1.39M | 0.42 | 628,047 | +141.21% | +$812,546.94 | <0.0001 | |
| Invenomic Capital Management LP | $1.34M | 0.41 | 604,512 | +6.31% | +$79,323.56 | 0.07 | |
| Stonepine Capital Management Llc | $1.32M | 0.4 | 598,086 | -89.93% | -$11.8M | 1.07 | |
| Tudor Investment Corp Et Al | $1.27M | 0.39 | 573,186 | +3.57% | +$43,702.75 | 0.02 | |
| LAZARD ASSET MANAGEMENT LLC | $929,000.00 | 0.28 | 420,487 | +4.13% | +$36,838.58 | <0.01 | |
| Nea Management Company Llc | $926,211.00 | 0.28 | 419,100 | New | +$926,211.00 | 0.01 | |
| Wellington Management Company | $877,248.00 | 0.27 | 396,945 | New | +$877,248.00 | <0.0001 | |
| JPMorgan Chase | $827,325.00 | 0.25 | 374,355 | +16.1% | +$114,741.05 | <0.0001 | |
| Charles Schwab | $809,508.00 | 0.25 | 366,293 | +0.52% | +$4,223.31 | <0.0001 | |
| BNY Mellon | $770,271.00 | 0.24 | 348,539 | -5.91% | -$48,405.62 | <0.0001 | |
| Helm Capital Management LLC | $687,219.00 | 0.21 | 310,959 | New | +$687,219.00 | 0.02 | |
| Alpine Global Management, LLC | $663,000.00 | 0.2 | 300,000 | +11.11% | +$66,300.00 | 0.04 | |
| IHT Wealth Management | $659,404.00 | 0.2 | 298,367 | +6.79% | +$41,935.57 | 0.02 | |
| Schonfeld Group | $642,000.00 | 0.2 | 290,498 | New | +$642,000.00 | 0.01 | |
| Xtx Topco Ltd | $563,658.00 | 0.17 | 255,049 | +1,447.06% | +$527,223.96 | 0.03 | |
| Goldman Sachs | $555,700.00 | 0.17 | 251,448 | -2.8% | -$16,002.61 | <0.0001 | |
| Jane Street Capital | $508,207.00 | 0.16 | 229,958 | +2.85% | +$14,086.53 | <0.01 | |
| Barclays | $453,000.00 | 0.14 | 204,973 | -25.72% | -$156,891.25 | <0.0001 | |
| Man Group Plc | $439,841.00 | 0.13 | 199,023 | New | +$439,841.00 | <0.01 | |
| UBS | $434,515.00 | 0.13 | 196,613 | +46.28% | +$137,464.30 | <0.0001 | |
| TSW (Thompson, Siegel & Walmsley LLC) | $420,000.00 | 0.13 | 190,000 | New | +$420,000.00 | 0.01 | |
| Brown Advisory | $420,464.00 | 0.13 | 190,255 | -10% | -$46,741.55 | <0.01 | |
| Hrt Financial Llc | $402,000.00 | 0.12 | 182,324 | +108.77% | +$209,440.23 | <0.01 | |
| RhumbLine Advisers | $392,572.00 | 0.12 | 177,638 | +3.71% | +$14,024.38 | <0.0001 | |
| Qube Research & Technologies | $394,622.00 | 0.12 | 178,562 | New | +$394,622.00 | <0.0001 | |
| Diversified Trust Co | $388,389.00 | 0.12 | 175,741 | +12.91% | +$44,401.27 | 0.01 | |
| Financial Holdings Ltd/ Can Fairfax | $333,069.00 | 0.1 | 151,395 | 0% | +$0 | 0.03 | |
| Two Sigma | $286,999.00 | 0.09 | 129,864 | +33.4% | +$71,858.04 | <0.0001 | |
| T. Rowe Price | $278,000.00 | 0.09 | 125,635 | +9.24% | +$23,526.06 | <0.0001 | |
| Cetera Advisor Networks LLC | $259,863.00 | 0.08 | 117,585 | +0.51% | +$1,314.95 | <0.01 | |
| Parkman Healthcare Partners Llc | $222,494.00 | 0.07 | 100,676 | New | +$222,494.00 | 0.03 | |
| Mariner Llc | $216,737.00 | 0.07 | 98,071 | -24.2% | -$69,215.02 | <0.0001 | |
| Citadel Advisors LLC | $210,719.00 | 0.06 | 95,348 | -76.2% | -$674,555.83 | <0.0001 | |
| Graham Capital Management, L.P. | $191,428.00 | 0.06 | 86,619 | +135.48% | +$110,135.36 | 0.01 |